The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis

被引:73
|
作者
O'Dwyer, Donna [1 ]
Ralton, Lynda D. [1 ]
O'Shea, Aisling [1 ]
Murray, Graeme I. [1 ]
机构
[1] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
来源
PLOS ONE | 2011年 / 6卷 / 11期
基金
英国生物技术与生命科学研究理事会;
关键词
POOR-PROGNOSIS; EXPRESSION; MARKERS; BIOMARKERS; THERAPY; HSP60; CYTOCHROME-P450; PREDICTION; ANNEXINS; GROWTH;
D O I
10.1371/journal.pone.0027718
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography-tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography-tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p < 0.001), S100A9 (p < 0.001) and translationally controlled tumour protein (p, 0.001). Analysis of proteins individually identified 14-3-3 beta as a prognostic biomarker (chi(2) = 6.218, p = 0.013, HR = 0.639, 95% CL 0.448-0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3b and aldehyde dehydrogenase 1 was identified as showing prognostic significance (chi(2) = 7.306, p = 0.007, HR = 0.504, 95% CL 0.303-0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95% CL 0.208-0.829) in a multivariate model.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer
    Li, Xianzhe
    Xie, Minghao
    Yin, Shi
    Xiong, Zhizhong
    Mao, Chaobin
    Zhang, Fengxiang
    Chen, Huaxian
    Jin, Longyang
    Lan, Ping
    Lian, Lei
    FRONTIERS IN GENETICS, 2021, 12
  • [22] Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients
    Dai, Siqi
    Xu, Shuang
    Ye, Yao
    Ding, Kefeng
    FRONTIERS IN GENETICS, 2020, 11
  • [23] An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer
    Xiong, Yongfu
    Wang, Rong
    Peng, Linglong
    You, Wenxian
    Wei, Jinlai
    Zhang, Shouru
    Wu, Xingye
    Guo, Jinbao
    Xu, Jun
    Lv, Zhenbing
    Fu, Zhongxue
    ONCOTARGET, 2017, 8 (49) : 85463 - 85478
  • [24] A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer
    Li, Dong-hai
    Du, Xiao-hui
    Liu, Ming
    Zhang, Rui
    CANCER GENETICS, 2021, 252 : 80 - 86
  • [25] Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer
    Wang, Xiao
    Li, Tianzuo
    BIOENGINEERED, 2020, 11 (01) : 165 - 174
  • [26] MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance
    Baharudin, Rashidah
    Rus Bakarurraini, Nurul Qistina
    Ismail, Imilia
    Lee, Learn-Han
    Ab Mutalib, Nurul Syakima
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [27] Identification of a gene signature associated with radiotherapy and prognosis in gliomas
    Li, Shu
    Shi, Juanhong
    Gao, Hongliang
    Yuan, Yan
    Chen, Qi
    Zhao, Zhenyu
    Wang, Xiaoqiang
    Li, Bin
    Ming, LinZhao
    Zhong, Jun
    Zhou, Ping
    He, Hua
    Tao, Bangbao
    Li, Shiting
    ONCOTARGET, 2017, 8 (51) : 88974 - 88987
  • [28] Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer
    Fan, Zhi-yuan
    Liu, Wentao
    Yan, Chao
    Zhu, Zheng-lun
    Xu, Wei
    Li, Jian-fang
    Su, Liping
    Li, Chen
    Zhu, Zheng-gang
    Liu, Bingya
    Yan, Min
    TUMOR BIOLOGY, 2016, 37 (10) : 13265 - 13277
  • [29] Yes-associated protein expression is associated with poor prognosis in patients with colorectal cancer
    Cao, Liyu
    Zhang, Cong
    Wu, Qingqing
    Bai, Zhenzhen
    Chen, Jing
    ONCOLOGY LETTERS, 2021, 22 (03)
  • [30] Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer
    Shu, Wan
    Wang, Ziwei
    Zhang, Wei
    Zhang, Jun
    Zhao, Rong
    Yu, Zhicheng
    Dong, Kejun
    Wang, Hongbo
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (08) : 1488 - 1502